No title
Respiratory diseases are a major global health challenge where current inhalation medication is primarily by oral inhalation. An alternative administration route is by nasal inhalation allowing for rapid drug absorption, high patient compliance and avoidance of the first-pass effect. Despite its potential for local and systemic drug delivery there is limited research on active inhalation of dry po
